Authorizations for the PAGETEX clinical trial

 The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.

End of the evaluation of the PHOSISTOS® project

Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission

Start of the PAGETEX clinical trial

The first patient with Paget's disease has been treated by the PAGETEX clinical protocol.

Light emitting fabrics in dermatology

Prof. Mortier presented this technology on Europe 1 radio

Back